Ofloxacin

Results: 449



#Item
81These highlights do not include all the information needed to use LEVAQUIN® safely and effectively. See full prescribing information for LEVAQUIN®. LEVAQUIN® (levofloxacin) Tablet, Film Coated for Oral use LEVAQUIN®

These highlights do not include all the information needed to use LEVAQUIN® safely and effectively. See full prescribing information for LEVAQUIN®. LEVAQUIN® (levofloxacin) Tablet, Film Coated for Oral use LEVAQUIN®

Add to Reading List

Source URL: www.fda.gov

Language: English
82Department of Health and Human Services Public Health Service Food and Drug Administration Center for Drug Evaluation and Research Office of Surveillance and Epidemiology Pediatric Postmarketing Pharmacovigilance and Dru

Department of Health and Human Services Public Health Service Food and Drug Administration Center for Drug Evaluation and Research Office of Surveillance and Epidemiology Pediatric Postmarketing Pharmacovigilance and Dru

Add to Reading List

Source URL: www.fda.gov

Language: English
83Collaborative Practice: Tips on when to refer to CHOP Otolaryngology Recurrent Acute Otitis Media • Not an urgent referral, may take 4-6 weeks for a new patient visit. • Plan Ahead. • Refer for 3-6 AOM in 6 months.

Collaborative Practice: Tips on when to refer to CHOP Otolaryngology Recurrent Acute Otitis Media • Not an urgent referral, may take 4-6 weeks for a new patient visit. • Plan Ahead. • Refer for 3-6 AOM in 6 months.

Add to Reading List

Source URL: media.chop.edu

Language: English - Date: 2014-08-19 15:15:13
84[removed]Federal Register / Vol. 70, No[removed]Wednesday, May 25, [removed]Notices information within the meaning of the Freedom of Information Act and FDA’s

[removed]Federal Register / Vol. 70, No[removed]Wednesday, May 25, [removed]Notices information within the meaning of the Freedom of Information Act and FDA’s

Add to Reading List

Source URL: www.fda.gov

Language: English - Date: 2005-05-25 09:03:55
85(ciprofloxacin HCl ophthalmic solution) 0.3% as base Sterile DESCRIPTION: CILOXAN® (ciprofloxacin HCl ophthalmic solution) is a synthetic, sterile, multiple dose, antimicrobial for topical ophthalmic use. Ciprofloxacin

(ciprofloxacin HCl ophthalmic solution) 0.3% as base Sterile DESCRIPTION: CILOXAN® (ciprofloxacin HCl ophthalmic solution) is a synthetic, sterile, multiple dose, antimicrobial for topical ophthalmic use. Ciprofloxacin

Add to Reading List

Source URL: ecatalog.alcon.com

Language: English - Date: 2014-08-21 13:03:08
86CATALOG  LEVOFLOXACIN The convenience of premix bags and vials Our Offering is ExtensIV

CATALOG LEVOFLOXACIN The convenience of premix bags and vials Our Offering is ExtensIV

Add to Reading List

Source URL: www.sagentpharma.com

Language: English - Date: 2014-09-09 17:14:38
87PRODUCT MONOGRAPH  Pr UNIPHYL®

PRODUCT MONOGRAPH Pr UNIPHYL®

Add to Reading List

Source URL: www.purdue.ca

Language: English - Date: 2014-10-02 14:14:07
88CATALOG  CIPROFLOXACIN Premix IV bags with distinctive color overwraps to aid in easy identification

CATALOG CIPROFLOXACIN Premix IV bags with distinctive color overwraps to aid in easy identification

Add to Reading List

Source URL: www.sagentpharma.com

Language: English - Date: 2014-08-11 13:36:01
89CIPROFLOXACIN INJECTION, USP For Intravenous Infusion Staphylococcus hominis (methicillin-susceptible isolates only) Bacillus anthracis

CIPROFLOXACIN INJECTION, USP For Intravenous Infusion Staphylococcus hominis (methicillin-susceptible isolates only) Bacillus anthracis

Add to Reading List

Source URL: www.sagentpharma.com

Language: English - Date: 2014-08-11 13:36:04
90Microsoft Word - 20141212_DSEP新製品発売リリース_EN_final.docx

Microsoft Word - 20141212_DSEP新製品発売リリース_EN_final.docx

Add to Reading List

Source URL: www.daiichisankyo.com

Language: English - Date: 2014-12-26 02:36:41